BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20007487)

  • 1. Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling.
    Glading AJ; Ginsberg MH
    Dis Model Mech; 2010; 3(1-2):73-83. PubMed ID: 20007487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRIT1 protein depletion modifies endothelial cell behavior via increased vascular endothelial growth factor (VEGF) signaling.
    DiStefano PV; Kuebel JM; Sarelius IH; Glading AJ
    J Biol Chem; 2014 Nov; 289(47):33054-65. PubMed ID: 25320085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanism of Rap1-induced stabilization of endothelial cell--cell junctions.
    Liu JJ; Stockton RA; Gingras AR; Ablooglu AJ; Han J; Bobkov AA; Ginsberg MH
    Mol Biol Cell; 2011 Jul; 22(14):2509-19. PubMed ID: 21633110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.
    Stockton RA; Shenkar R; Awad IA; Ginsberg MH
    J Exp Med; 2010 Apr; 207(4):881-96. PubMed ID: 20308363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EndMT contributes to the onset and progression of cerebral cavernous malformations.
    Maddaluno L; Rudini N; Cuttano R; Bravi L; Giampietro C; Corada M; Ferrarini L; Orsenigo F; Papa E; Boulday G; Tournier-Lasserve E; Chapon F; Richichi C; Retta SF; Lampugnani MG; Dejana E
    Nature; 2013 Jun; 498(7455):492-6. PubMed ID: 23748444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions.
    Glading A; Han J; Stockton RA; Ginsberg MH
    J Cell Biol; 2007 Oct; 179(2):247-54. PubMed ID: 17954608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for small G protein effector interaction of Ras-related protein 1 (Rap1) and adaptor protein Krev interaction trapped 1 (KRIT1).
    Li X; Zhang R; Draheim KM; Liu W; Calderwood DA; Boggon TJ
    J Biol Chem; 2012 Jun; 287(26):22317-27. PubMed ID: 22577140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCM1 and the second life of proteins in adhesion complexes.
    van den Berg MC; Burgering BM
    Cell Adh Migr; 2014; 8(2):146-57. PubMed ID: 24714220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCM1 regulates vascular-lumen organization by inducing endothelial polarity.
    Lampugnani MG; Orsenigo F; Rudini N; Maddaluno L; Boulday G; Chapon F; Dejana E
    J Cell Sci; 2010 Apr; 123(Pt 7):1073-80. PubMed ID: 20332120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction.
    Faurobert E; Albiges-Rizo C
    FEBS J; 2010 Mar; 277(5):1084-96. PubMed ID: 20096036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel KRIT1/CCM1 Gene Insertion Mutation Associated with Cerebral Cavernous Malformations in a Chinese Family.
    Wang H; Pan Y; Zhang Z; Li X; Xu Z; Suo Y; Li W; Wang Y
    J Mol Neurosci; 2017 Feb; 61(2):221-226. PubMed ID: 28160210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations within KRIT1/CCM1, MGC4607/CCM2 and PDCD10/CCM3 in a large Italian family harbouring a Krit1/CCM1 mutation.
    Pileggi S; Buscone S; Ricci C; Patrosso MC; Marocchi A; Brunori P; Battistini S; Penco S
    J Mol Neurosci; 2010 Oct; 42(2):235-42. PubMed ID: 20419355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of the junctional anchorage of the cerebral cavernous malformations complex.
    Gingras AR; Liu JJ; Ginsberg MH
    J Cell Biol; 2012 Oct; 199(1):39-48. PubMed ID: 23007647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1).
    Kehrer-Sawatzki H; Wilda M; Braun VM; Richter HP; Hameister H
    Acta Neuropathol; 2002 Sep; 104(3):231-40. PubMed ID: 12172908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallographic Studies of the Cerebral Cavernous Malformations Proteins.
    Fisher OS; Li X; Liu W; Zhang R; Boggon TJ
    Methods Mol Biol; 2020; 2152():291-302. PubMed ID: 32524560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.
    Pagenstecher A; Stahl S; Sure U; Felbor U
    Hum Mol Genet; 2009 Mar; 18(5):911-8. PubMed ID: 19088124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations.
    Rath M; Jenssen SE; Schwefel K; Spiegler S; Kleimeier D; Sperling C; Kaderali L; Felbor U
    Eur J Med Genet; 2017 Sep; 60(9):479-484. PubMed ID: 28645800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-21 coordinates tumor growth and modulates KRIT1 levels.
    Orso F; Balzac F; Marino M; Lembo A; Retta SF; Taverna D
    Biochem Biophys Res Commun; 2013 Aug; 438(1):90-6. PubMed ID: 23872064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenteric cysts, lymphatic leak, and cerebral cavernous malformation in a proband with KRIT1-related disease.
    Moller-Hansen A; Huynh S; Boerkoel CF; Chin HL
    Am J Med Genet A; 2022 Jan; 188(1):332-335. PubMed ID: 34558799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations.
    Fisher OS; Liu W; Zhang R; Stiegler AL; Ghedia S; Weber JL; Boggon TJ
    J Biol Chem; 2015 Jan; 290(5):2842-53. PubMed ID: 25525273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.